» Articles » PMID: 19172249

Abnormal Pain Response in Pain-sensitive Opiate Addicts After Prolonged Abstinence Predicts Increased Drug Craving

Overview
Specialty Pharmacology
Date 2009 Jan 28
PMID 19172249
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Craving is a primary feature of opiate addiction and is clinically significant because of its potential to trigger opiate use and relapse. Opiate use can also produce abnormal pain perception. We predicted that for opiate addicts (OAs), there may be an association between these two major features of addiction (drug craving and abnormal pain responses).

Objectives: To examine pain responses in abstinent opiate addicts in comparison with healthy controls using a cold-pressor test (CPT) and investigate the correlations of cue-induced drug craving with pain responses.

Material And Methods: Fifty-four abstinent OAs and 46 healthy subjects participated in the CPT, and the OAs were also exposed to heroin-related cues the day before the pain test. Outcome measures included pain-tolerance time, VAS ratings of pain intensity and distress, and (in the cue-exposure procedure) VAS ratings of heroin craving and anxiety.

Results: In the CPT, abstinent addicts showed shorter pain-tolerance time (85.1 +/- 14.1 s vs. 133.7 +/- 16.7 s, p < 0.05) and higher ratings of pain distress (61 +/- 3.2 vs. 45.6 +/- 3.2, p < 0.01) compared to healthy controls. When we divided the addicts and controls into pain-sensitive (PS) and pain-tolerant (PT) groups by dichotomizing each group in terms of pain-tolerance time, we again found differences between the two PS groups (37.3 +/- 3.5 s vs. 57.4 +/- 5.1 s, p < 0.01 for pain-tolerance time; 66.7 +/- 3.2 vs. 52.4 +/- 3.3, p < 0.01 for distress ratings). For all participants, pain-tolerance time was negatively correlated with VAS ratings for pain intensity and distress. More importantly, the PS addicts reported greater cue-induced craving than the PT addicts (17.8 +/- 2.2 vs. 4.5 +/- 4.2, p < 0.05). For the addict group as a whole, pain distress (the affective aspect of pain) was positively correlated with intensity of cue-induced craving measured on a different day (r = 0.33, p = 0.01).

Conclusions: A hyperalgesic state persists for at least 5 months in abstinent OAs and is predictive of cue-induced craving. Longitudinal research is needed to clarify the direction of causation between hyperalgesia and opiate addiction.

Citing Articles

Genome-wide association study reveals multiple loci for nociception and opioid consumption behaviors associated with heroin vulnerability in outbred rats.

Kuhn B, Cannella N, Chitre A, Nguyen K, Cohen K, Chen D Mol Psychiatry. 2025; .

PMID: 40000848 DOI: 10.1038/s41380-025-02922-4.


Art therapy's engagement of brain networks for enduring recovery from addiction.

Quinn P Front Psychiatry. 2025; 15():1458063.

PMID: 39834572 PMC: 11743619. DOI: 10.3389/fpsyt.2024.1458063.


Persistent effects of repeated adolescent and adult heroin vapor inhalation in female Wistar rats.

Gutierrez A, Taffe M bioRxiv. 2024; .

PMID: 38765990 PMC: 11100616. DOI: 10.1101/2024.05.06.592492.


The relationship of pain intensity and opioid craving with delayed methadone dose: A preliminary study of individuals with opioid use disorder.

MacLean R, Spinola S, Pittman B, Meyerovich J, Szollosy S, Wolkowicz N Br J Clin Pharmacol. 2024; 90(12):2977-2984.

PMID: 38439592 PMC: 11613043. DOI: 10.1111/bcp.16027.


Predictors of concurrent heroin use among patients on opioid maintenance treatment in France: a multilevel study over 11 years.

Janssen E, Vuolo M, Spilka S, Airagnes G Harm Reduct J. 2024; 21(1):15.

PMID: 38243253 PMC: 10799399. DOI: 10.1186/s12954-024-00934-x.


References
1.
Alford D, Compton P, Samet J . Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med. 2006; 144(2):127-34. PMC: 1892816. DOI: 10.7326/0003-4819-144-2-200601170-00010. View

2.
Liebmann P, Lehofer M, Moser M, Hoehn-Saric R, Legl T, Pernhaupt G . Persistent analgesia in former opiate addicts is resistant to blockade of endogenous opioids. Biol Psychiatry. 1997; 42(10):962-4. DOI: 10.1016/S0006-3223(97)00337-5. View

3.
Chu L, Angst M, Clark D . Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain. 2008; 24(6):479-96. DOI: 10.1097/AJP.0b013e31816b2f43. View

4.
Martin J, Inglis J . Pain tolerance and narcotic addiction. Br J Soc Clin Psychol. 1965; 4(3):224-9. DOI: 10.1111/j.2044-8260.1965.tb00467.x. View

5.
Ooteman W, Koeter M, Vserheul R, Schippers G, van den Brink W . Measuring craving: an attempt to connect subjective craving with cue reactivity. Alcohol Clin Exp Res. 2006; 30(1):57-69. DOI: 10.1111/j.1530-0277.2006.00019.x. View